CompBioMed e-Seminars

This page provides you access to the 32 CompBioMed e-Seminars, with both the video and slides available by clicking on each logo below.

At the end of this page, we present the statistics of attendees from e-Seminars 11 to 32.

Recording Available!

Recording available!

The Statistics of the CompBioMed e-Seminar Series

The e-Seminar series has been running since the start of CompBioMed; however, detailed attendee characteristics were gathered only for e-Seminars #12 to #32.

The CompBioMed e-Seminar Series included at least 4 events per year (two technical and two scientific) and was produced and advertised in collaboration with the VPH Institute: https://www.vph-institute.org/.

The gender of attendees was 55% male, 25% female, 15% no response, 5% prefer not to say, and 1 non-binary. Through our e-Seminars programme we are also encouraging female participation, and we had four female speakers, #27, #30, and #31, and two female chairs. For this second half of the final phase of CompBioMed, the percentage of female attendees increased from 12% to 32%.

The following graphs shows the number of attendees per seminars #11 to #32. The first shows the number of registrations per e-Seminar along with the number of attendees. The second show the attendee numbers subdivided by the number of those from particular affiliations.

Regarding industry engagement in general, the SME mini-series (#23-#26) saw a 3x increase in attendees from SMEs. On the other hand, no SMEs attended #15, #18, #22 and #27, which were “POP CoE”, “1st Containers”, “GPUs for HPC”, and “EMF and DNA”. The e-Seminar #19, “Technical Alya”, had the least diverse: just academia and two from SMEs. Overall, #14 had the largest attendance (Molecule viz using PyMOL), whilst #25 had the largest SME and Large Enterprise (Drug discovery with ML and HPC). The second largest attendance was #22 and zero SMEs: ‘Nvida: GPUs for HPC’. Big companies were attracted to #13, #14, #17, #25 which were “ML”, “Molecule Viz”, “ML” again, and “ML+HPC”, respectively, whilst Hospitals and Clinics favoured #28 (Bone fractures using HPC).

The series was attended predominantly by academics; however, the 2nd largest number were from Medical, Pharma and Biotech companies. After “Other”, we saw a combined 5.15% from “Healthcare Software” and “Other Software”.

In terms of the EU, the heatmap of attendees is displayed below, alongside the world heat map clearly indicating the global reach of our work. The number of attendees from each group of countries was, HPC Poor+EU13: 12%, Rest of EU+UK: 63%, Other: 12%, and No response: 13%.

World heat map of the location of attendees to the e-Seminar series

Finally, of all the attendees, 12% returned the questionnaire, with 96% stating they would recommend our e-Seminar series, with averaged marks out of 10 of 8.9 overall, with 8.8 saying it was useful and 8.8 stating it met or exceeded their expectations.